litlas
ログインアカウント作成

Richard S.E. Keefe

1987–2025 年に発表

139
論文数
36,741
被引用数
96
h 指数
138
i10 指数

被引用数

Richard S.E. Keefe の年別被引用数1940 年: 被引用 1 件1988 年: 被引用 2 件1989 年: 被引用 4 件1990 年: 被引用 2 件1991 年: 被引用 8 件1992 年: 被引用 8 件1993 年: 被引用 15 件1994 年: 被引用 8 件1995 年: 被引用 12 件1996 年: 被引用 14 件1997 年: 被引用 9 件1998 年: 被引用 12 件1999 年: 被引用 28 件2000 年: 被引用 35 件2001 年: 被引用 32 件2002 年: 被引用 55 件2003 年: 被引用 57 件2004 年: 被引用 53 件2005 年: 被引用 126 件2006 年: 被引用 215 件2007 年: 被引用 318 件2008 年: 被引用 353 件2009 年: 被引用 396 件2010 年: 被引用 466 件2011 年: 被引用 354 件2012 年: 被引用 379 件2013 年: 被引用 378 件2014 年: 被引用 373 件2015 年: 被引用 354 件2016 年: 被引用 323 件2017 年: 被引用 274 件2018 年: 被引用 252 件2019 年: 被引用 1,029 件2020 年: 被引用 869 件2021 年: 被引用 777 件2022 年: 被引用 646 件2023 年: 被引用 402 件2024 年: 被引用 847 件2025 年: 被引用 261 件2026 年: 被引用 15 件1941〜1987 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,433 件、この内訳の 31.8%イギリス: 引用元論文 1,050 件、この内訳の 9.7%カナダ: 引用元論文 624 件、この内訳の 5.8%ドイツ: 引用元論文 571 件、この内訳の 5.3%中国: 引用元論文 506 件、この内訳の 4.7%オーストラリア: 引用元論文 499 件、この内訳の 4.6%イタリア: 引用元論文 438 件、この内訳の 4.1%オランダ: 引用元論文 323 件、この内訳の 3%スペイン: 引用元論文 316 件、この内訳の 2.9%日本: 引用元論文 250 件、この内訳の 2.3%スイス: 引用元論文 236 件、この内訳の 2.2%フランス: 引用元論文 198 件、この内訳の 1.8%
0%31.8%その他 21.8%

機関

分野

  • Medicine58.7%
  • Neuroscience21.4%
  • Biochemistry, Genetics and Molecular Biology8.7%
  • Psychology6.9%
  • Health Professions0.9%
  • Computer Science0.7%
  • その他2.7%

トピック

  • Schizophrenia research and treatment17.6%
  • Functional Brain Connectivity Studies4.9%
  • Tryptophan and brain disorders4.2%
  • Mental Health and Psychiatry4.1%
  • Bipolar Disorder and Treatment3.8%
  • Treatment of Major Depression2.6%
  • その他62.8%

共著者

全論文

検索で開く
  1. Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment

    著者: Robert A. McCutcheon, Richard S.E. Keefe, Philip McGuire - Molecular Psychiatry 2023 被引用: 710

  2. The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity

    著者: Keith H. Nuechterlein, Michael F. Green, Robert S Kern, Lyle E. Baade, Deanna M. Barch, Jonathan D. Cohen, Susan M. Essock, Wayne S. Fenton, Frederick J. Frese, James M. Gold, Terry E. Goldberg, Robert K. Heaton, Richard S.E. Keefe, Helena C. Kraemer, Raquelle I. Mesholam‐Gately, Larry J. Seidman, Ellen Stover, Daniel R. Weinberger, Alexander S. Young, Steven Zalcman, Stephen R. Marder - American Journal of Psychiatry 2008 被引用: 2,319

  3. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery

    著者: Richard S.E. Keefe - Schizophrenia Research 2003 被引用: 1,565

  4. Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

    著者: Jeffrey A. Lieberman, T. Scott Stroup, Joseph P. McEvoy, Marvin S. Swartz, Robert A. Rosenheck, Diana O. Perkins, Richard S.E. Keefe, Sonia M. Davis, C.E. Davis, Barry D. Lebowitz, Joanne B. Severe, John Hsiao - New England Journal of Medicine 2005 被引用: 5,895

  5. A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial

    著者: Scott H. Kollins, Denton DeLoss, Elena Cañadas, J. Gary Lutz, Robert L. Findling, Richard S.E. Keefe, Jeffery N. Epstein, Andrew J. Cutler, Stephen V. Faraone - The Lancet Digital Health 2020 被引用: 388

  6. The MATRICS Consensus Cognitive Battery, Part 2: Co-Norming and Standardization

    著者: Robert S Kern, Keith H. Nuechterlein, Michael F. Green, Lyle E. Baade, Wayne S. Fenton, James M. Gold, Richard S.E. Keefe, Raquelle I. Mesholam‐Gately, Jim Mintz, Larry J. Seidman, Ellen Stover, Stephen R. Marder - American Journal of Psychiatry 2008 被引用: 749

  7. A randomized proof-of-mechanism trial applying the ‘fast-fail’ approach to evaluating κ-opioid antagonism as a treatment for anhedonia

    著者: Andrew D. Krystal, Diego A. Pizzagalli, Moria J. Smoski, Sanjay J. Mathew, John I. Nürnberger, Sarah H. Lisanby, Dan V. Iosifescu, James W. Murrough, Hongqiu Yang, Richard D. Weiner, Joseph R. Calabrese, Gerard Sanacora, Gretchen Hermes, Richard S.E. Keefe, Allen W. Song, Wayne K. Goodman, Steven T. Szabo, Alexis E. Whitton, Keming Gao, William Z. Potter - Nature Medicine 2020 被引用: 229

  8. Schizophrenia Is a Cognitive Illness

    著者: René S. Kahn, Richard S.E. Keefe - JAMA Psychiatry 2013 被引用: 825

  9. Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 study

    著者: W. Wolfgang Fleischhacker, Jana Podhorná, Martina Gröschl, Sanjay Hake, Yihua Zhao, Songqiao Huang, Richard S.E. Keefe, Michael Desch, Ronald Brenner, David P. Walling, E. Mantero-Atienza, Kazuyuki Nakagome, Stephane Pollentier - The Lancet Psychiatry 2021 被引用: 134

  10. Neurocognitive Effects of Antipsychotic Medications in Patients With Chronic Schizophrenia in the CATIE Trial

    著者: Richard S.E. Keefe - Archives of General Psychiatry 2007 被引用: 1,070

  11. Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria

    著者: Michael F. Green, Keith H. Nuechterlein, James M. Gold, Deanna M. Barch, Jonathan D. Cohen, Susan M. Essock, Wayne S. Fenton, Fred Frese, Terry E. Goldberg, Robert K. Heaton, Richard S.E. Keefe, Robert S Kern, Helena C. Kraemer, Ellen Stover, Daniel R. Weinberger, Steven Zalcman, Stephen R. Marder - Biological Psychiatry 2004 被引用: 917

  12. Static and Dynamic Cognitive Deficits in Childhood Preceding Adult Schizophrenia: A 30-Year Study

    著者: Abraham Reichenberg, Avshalom Caspi, HonaLee Harrington, Renate Houts, Richard S.E. Keefe, Robin Murray, Richie Poulton, Terrie E. Moffitt - American Journal of Psychiatry 2010 被引用: 557

  13. Persistent cannabis users show neuropsychological decline from childhood to midlife

    著者: Madeline H. Meier, Avshalom Caspi, Antony Ambler, HonaLee Harrington, Renate Houts, Richard S.E. Keefe, Kay McDonald, Aimee L. Ward, Richie Poulton, Terrie E. Moffitt - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 被引用: 1,521

  14. Cognitive Impairment in Schizophrenia

    著者: Richard S.E. Keefe, Philip D. Harvey - Handbook of experimental pharmacology 2012 被引用: 470

  15. Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS)

    著者: Richard S.E. Keefe, Philip D. Harvey, Terry E. Goldberg, James M. Gold, T WALKER, Courtney Kennel, Kristina C. Hawkins - Schizophrenia Research 2008 被引用: 336

  16. The Schizophrenia Cognition Rating Scale: An Interview-Based Assessment and Its Relationship to Cognition, Real-World Functioning, and Functional Capacity

    著者: Richard S.E. Keefe, Margaret P. Poe, Trina M. Walker, Joseph W. Kang, Philip D. Harvey - American Journal of Psychiatry 2006 被引用: 391

  17. Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment

    著者: Joseph P. McEvoy, Jeffrey A. Lieberman, T. Scott Stroup, Sonia M. Davis, Herbert Y. Meltzer, Robert A. Rosenheck, Marvin S. Swartz, Diana O. Perkins, Richard S.E. Keefe, C.E. Davis, Joanne B. Severe, John Hsiao, for the CATIE Investigators - American Journal of Psychiatry 2006 被引用: 755

  18. A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder

    著者: Atul R. Mahableshwarkar, John Zajecka, W. Jacobson, Yinzhong Chen, Richard S.E. Keefe - Neuropsychopharmacology 2015 被引用: 309

  19. Brief Assessment of Cognition in Schizophrenia: Validation of the Japanese version

    著者: Y Kaneda, Tomiki Sumiyoshi, Richard S.E. Keefe, Yasuhito Ishimoto, Shusuke Numata, Tetsuro Ohmori - Psychiatry and Clinical Neurosciences 2007 被引用: 255

  20. Antipsychotic Drugs and Cognitive Function

    著者: Lena Feber, Natalie Peter, Virginia Chiocchia, Johannes Schneider‐Thoma, Spyridon Siafis, Irene Bighelli, Wulf‐Peter Hansen, Xiao Lin, Daniel Prates-Baldez, Georgia Salanti, Richard S.E. Keefe, Rolf R. Engel, Stefan Leucht - JAMA Psychiatry 2024 被引用: 83

  21. The MCCB impairment profile for schizophrenia outpatients: Results from the MATRICS psychometric and standardization study

    著者: Robert S Kern, James M. Gold, Dwight Dickinson, Michael F. Green, Keith H. Nuechterlein, Lyle E. Baade, Richard S.E. Keefe, Raquelle I. Mesholam‐Gately, Larry J. Seidman, Cathy Lee, Catherine A. Sugar, Stephen R. Marder - Schizophrenia Research 2010 被引用: 252

  22. Cognitive burden of anticholinergic medications in psychotic disorders

    著者: Seenae Eum, S. Kristian Hill, Leah H. Rubin, Ryan M. Carnahan, James L. Reilly, Elena I. Ivleva, Sarah Keedy, Carol A. Tamminga, Godfrey D. Pearlson, Brett A. Clementz, Elliot S. Gershon, Matcheri S. Keshavan, Richard S.E. Keefe, John A. Sweeney, Jeffrey R. Bishop - Schizophrenia Research 2017 被引用: 99

  23. Neuropsychological Impairments in Schizophrenia and Psychotic Bipolar Disorder: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study

    著者: S. Kristian Hill, James L. Reilly, Richard S.E. Keefe, James M. Gold, Jeffrey R. Bishop, Elliot S. Gershon, Carol A. Tamminga, Godfrey D. Pearlson, Matcheri S. Keshavan, John A. Sweeney - American Journal of Psychiatry 2013 被引用: 363

  24. Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial

    著者: Richard S.E. Keefe, Kolleen H. Fox, Philip D. Harvey, Josephine Cucchiaro, Cynthia Siu, Antony Loebel - Schizophrenia Research 2010 被引用: 235